• Skip to primary navigation
  • Skip to main content
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • SAGES Store
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
    • “Unofficial” Logo Products
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2024 Scientific Session Call For Abstracts
      • 2024 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Fellows Career Development Course
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • OWLS
  • Log In

SAGES COVID-19 / Coronavirus Announcement Archives

SAGES will compile all of its announcements and recommendations regarding Covid-19/Coronavirus at this location.  Please bookmark it for your convenience.


General Disclaimer:

The following is intended to provide our members with additional information to help manage surgical patients during the COVID-19 pandemic. These are not formal guidelines and due to time constraints, SAGES has not reviewed or authenticated them by utilizing its standard rigorous guidelines process. Statements and information are updated regularly and subject to change as more data becomes available.

Did you find this information helpful?

Please consider joining SAGES or making a donation to the SAGES Education and Research Foundation so we can continue to bring content like this to the surgical community for free.


 

Resources for Smoke & Gas Evacuation During Open, Laparoscopic, and Endoscopic Procedures

March 29, 2020 by SAGES Webmaster

Released 3/29/2020 – this document will continue to be updated as needed.

Print Friendly, PDF & Email

Recently, SAGES, and/or SAGES in conjunction with EAES, published guidelines for surgeons concerning the use of laparoscopy during the current COVID-19 pandemic. We recognize that during this time of challenge to resources and personnel, every surgeon and institution is providing the very best care it can with the circumstances it finds itself in. This document represents a resource for smoke and gas evacuation based on known science, vetted publications, and potential strategies that offer the best protection to both patients and the health care team. This document is designed as a “living document” of resources and will be regularly updated when new evidence presents.

The Science of SARS-CoV-2

There is a constant influx of new information regarding the virology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease, COVID-19.  What we know so far regarding the SARS-CoV-2, is the RNA virus has a size range of 0.06 to 0.14 microns3.  Along with the nasopharynx, the upper respiratory tract and lower respiratory tract, the virus has been found in the entire gastrointestinal tract from the mouth to the rectum. The virus has been found in nasal swabs, saliva, sputum, throat swabs, blood, bile, and feces.  Urine and CSF evaluations have been negative. The virus has also been found within the cells lining the respiratory tract and gastrointestinal tract. It is suspected that the virus has multiple modes of transmission.

The potential of aerosolization as a mode of transmission during endoscopy or minimally invasive surgery is the focus of this document.

Filtration

Filtration may be an effective means of protection from the release of the virus during minimally invasive surgery (MIS) and endoscopy.  Masks such as N95 respirators are designed to filter out 95% of particles that are 0.3 microns and larger. Powered Air Purifying Respirators (PAPR) may be beneficial for intubation, extubation, bronchoscopy, endoscopy, and possibly tracheostomy. Intraoperatively, filters are used to remove smoke and particulate matter including viruses. High-Efficiency Particulate Air (HEPA) filters have a minimum 99.97% efficiency rating for removing particles greater than or equal to 0.3 microns in diameter4.  Ultra-Low Particulate Air (ULPA) filters can remove from a minimum of 99.999% of airborne particles with a minimum particle penetration size of 0.05 microns5. The Association of periOperative Registered Nurses (AORN) guidelines define ULPA as filters capable of removing particles of 0.1 microns. Filtration is also essential on a larger scale in the positive pressure operative suites. HEPA filters that are placed in the ceiling provide a terminal cleaning. Clean rooms are favored over HEPA filters placed in the ductwork.

Currently, the best practice for mitigating possible infectious transmission during open, laparoscopic and endoscopic procedures is to use a multi-faceted approach, which includes proper room filtration and ventilation, appropriate PPE, and smoke evacuation devices with a suction and filtration system,6 as available.

Practical Measures for Use of Filtration During Laparoscopy:

  1. All pneumoperitonuem should be safely evacuated from the port attached to the filtration device before closure, trocar removal, specimen extraction or conversion to open.
  2. Once placed, ports should not be vented if possible. If movement of the insufflating port is required, the port should be closed prior to disconnecting the tubing and the new port should be closed until the insufflator tubing is connected. The insufflator should be “on” before the new port valve is opened to prevent gas from back-flowing into the insufflator.
  3. During desufflation, all escaping CO2 gas and smoke should be captured with an ultra-filtration system and desufflation mode should be used on your insufflator if available.
  4. If the insufflator being used does not have a desufflation feature, be sure to close the valve on the working port that is being used for insufflation before the flow of CO2 on the insufflator is turned off (even if there is an in-line filter in the tubing).  Without taking this precaution contaminated intra-abdominal CO2 can be pushed into the insufflator when the intraabdominal pressure is higher than the pressure within the insufflator.
  5. The patient should be flat and the least dependent port should be utilized for desufflation.
  6. Specimens should be removed once all the CO2 gas and smoke is evacuated.
  7. Surgical drains should be utilized only if absolutely necessary.
  8. Suture closure devices that allow for leakage of insufflation should be avoided. The fascia should be closed after desufflation.
  9. Hand-assisted surgery can lead to significant leakage of insufflated CO2 and smoke from ports and should be avoided. If used to remove larger specimens and protect the wound, it can be placed after desufflation. The specimen can then be removed and the closure performed.

Smoke and Gas Evacuation Products

SAGES and EAES do not endorse any of the following products. This is a working list of commercially available products that could potentially be used to filter CO2 gas or smoke evacuated during open, laparoscopic, and endoscopic procedures. Please be aware of the products your facility utilizes and contact your manufacturer’s representative or refer to the product’s instructions for use (IFU) documents for further information. We have sought information from as many companies that we are aware of, but we understand there are many other companies that may have similar products. We will do our best to add information as it becomes available to us.  In addition to smoke evacuation products, the Ultravision system may minimize aerosolized particles within pneumoperitoneum.

Current wall suction devices do not use ultrafiltration.

Summary of Commercially Available Smoke Evacuation Systems

Please see our SAGES Medical Device Repository document for the summary.

References

  1. Surgical smoke and infection control. Alp E, Bijl D, Bleichrodt RP, Hansson B, Voss A. J Hosp Infect. 2006 Jan;62(1):1-5.
  2. Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery. Kwak HD, Kim SH, Seo YS, Song KJ. Occup Environ Med. 2016 Dec;73(12):857-863.
  3. China Novel Coronavirus Investigating and Research Team. Zhu N, Zhang D, Wang W1, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. N Engl J Med. 2020 Feb 20;382(8):727-733.
  4. Medical Advisory Secretariat. Air cleaning technologies: an evidence-based analysis. Ont Health Technol Assess Ser. 2005;5(17):1–52.
  5. SO 29463-1:2017 High Efficiency Filters And Filter Media For Removing Particles From Air – Part 1: Classification, Performance, Testing, And Marking.https://www.iso.org/obp/ui/#iso:std:iso:29463:-1:ed-2:v1:en.
  6. Surgical Smoke and the Orthopedic Implications. The Internet Journal of Orthopedic Surgery. Parsa RS, Dirig NF, Eck IN, Payne III WK. 2015, Volume 24 Number 1.
  7. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Wax RS, Christian MD. Can J Anaesth. 2020 Feb 12 [Epub ahead of print].
  8. Risk of acquiring human papilloma-virus from the plume produced by the carbon dioxide laser in the treatment of warts. Gloster HM Jr, Roenigk RK. J Am Acad Dermatol. 1995, 32:436–41.
  9. Surgical smoke may be a biohazard to surgeons performing laparoscopic surgery. Choi SH, Kwon TG, Chung SK, Kim TH. Surg Endosc. 2014, 28 (8): 2374-80.
  10. Experimental study of the potential hazards of surgical smoke from powered instruments. In SM, Park DY, Sohn IK, et al. Br J Surg. 2015, 102:1581––1586
  11. Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery. Kwak HD, Kim SH, Seo YS, et al. Occup Environ Med. 2016, 73:857––863
  12. Papillomavirus in the vapor of carbon dioxide laser-treated verrucae. Garden JM, O‘Banion MK, Shelnitz LS, et al. JAMA. 1988, 259:1199––1202
  13. Human papillomavirus DNA in CO2 laser-generated plume of smoke and its consequences to the surgeon. Ferenczy A, Bergeron C, Richart RM. Obstet Gynecol. 1990, 75:114-118
  14. Presence of human immunodeficiency virus DNA in laser smoke. Baggish MS, Poiesz BJ, Joret D, Williamson P, Refai A. Lasers Surg Med. 1991;11:197–203
  15. Studies on the transmission of viral disease via the CO2 laser plume and ejecta. Wisniewski PM, Warhol MJ, Rando RF, Sedlacek TV, Kemp JE, Fisher JC. J Reprod Med. 1990, 35:1117–23
  16. Interim Infection Prevention and Control Recommendations for Hospitalized Patients with Middle East Respiratory Syndrome Coronavirus (MERS-CoV). https://www.cdc.gov/coronavirus/mers/infection-prevention-control.html
  17. inimally invasive surgery and the novel coronavirus outbreak: lessons learned from Italy. Zheng MH, Boni L, Fingerhut A. Annals of Surgery. 2020. [Accepted for Publication].
  18. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gu J, Han B, Wang J. Gastroenterology. March 3 2020 [Epub ahead of print].
  19. ASGE | JOINT GI SOCIETY MESSAGE- COVID-19 Clinical insights for our community of gastroenterologists and gastroenterology care providers. https://www.asge.org/home/joint-gi-society-message-covid-19
  20. AORN J. 2017 May;105(5):488-497.
  21. COVID 19 AP 50 30 Information March 30 Lexion Medical
  22. AlwaysPneumo Brochure 8 page 2019 Lexion Medical
  23. Symmetry Surgical Smoke Evacuation Systems

Did you find this information helpful?
Please consider joining SAGES or making a donation to the SAGES Education and Research Foundation so we can continue to bring content like this to the surgical community for free.

Filed Under: Blog, COVID-19 Tagged With: filtration, smoke, surgical plume, systems

SAGES and EAES Recommendations Regarding Surgical Response to COVID-19 Crisis

March 29, 2020 by Aurora Pryor

Released 3/30/2020
Note: these recommendations are subject to change and update.

SAGES and EAES are committed to the protection and care of patients, their surgeons and staff, and all who are served by the medical community at large. We are making these recommendations based on best available evidence and expert opinion from the global surgical community. We will continue to monitor emerging evidence and support novel research to address these issues.

COVID-19 has demonstrated a propensity to spread at an exponential rate in several countries, significantly impacting many lives and affecting our practice as healthcare professionals. Through this prism, the following recommendations are being made with the aim that they can be of support to you, by addressing a number of uncertainties regarding our practice, own safety, and overall patient care.

Rationing of Services:

  1. All elective surgical and endoscopic cases should be postponed at the current time. These decisions however should be made locally, based on COVID-19 burden and in the context of medical, logistical and organizational considerations. There are different levels of urgency related to patient needs, and judgment is required to discern between them. However, as the numbers of COVID-19 patients requiring care is expected to escalate over the next few weeks, the surgical care of patients should be limited to those whose needs are imminently life threatening. These may include patients with malignancy that could progress, or with active symptoms that require urgent care. All others should be delayed until after the peak of the pandemic is seen. This minimizes the risk to both, patient and health care team, as well as minimizes utilization of necessary resources, such as beds, ventilators, and personal protective equipment (PPE).
  2. All non-essential hospital or office staff should be allowed to stay home and telework. All in-person educational sessions should be cancelled and could be replaced by online resources. The minimum number of necessary providers should attend patients during rounds and other encounters. Adherence to hand washing, antiseptic foaming, and appropriate use of PPE should be strictly enforced. When necessary, in-person surgical consultation should be performed by decision makers only.
  3. All non-urgent in-person clinic/office visits should be cancelled or postponed, unless needed to triage active symptoms or manage wound care. All patient visits should be handled remotely when possible, and in person only when absolutely necessary. Access to clinics should be maintained for those special circumstances to avoid patients seeking care in the ED. Only a minimum of required support personnel should be present for these visits, and PPE should again be appropriately utilized. When in critical need, consideration should be given to redeploying OR resources for intensive care needs.
  4. Multidisciplinary team (MDT) meetings should be held virtually as possible and/or limited to core team members only, including surgeon, pathologist, Clinical Nurse Specialist, radiologist, oncologist and coordinator. The MDT is responsible for the decision making and classifying the patient’s priority level of need for surgery.

Procedural Considerations:

  1. There is very little evidence regarding the relative risks of Minimally Invasive Surgery (MIS) versus the conventional open approach, specific to COVID-19. (1) We will therefore continue to monitor emerging evidence and support novel research to address these issues.
  2. It is strongly recommended however, that consideration be given to the possibility of viral contamination to staff during surgery either open, laparoscopic or robotic and that protective measures are strictly employed for OR staff safety and to maintain a functioning workforce.
  3. Although previous research has shown that laparoscopy can lead to aerosolization of blood borne viruses, (2-4) there is no evidence to indicate that this effect is seen with COVID-19, nor that it would be isolated to MIS procedures. Nevertheless, erring on the side of safety would warrant treating the coronavirus as exhibiting similar aerosolization properties. For MIS procedures, use of devices to filter released CO2 for aerosolized particles should be strongly considered.
  4. Proven benefits of MIS of reduced length of stay and complications should be strongly considered in these patients, in addition to the potential for ultrafiltration of the majority or all aerosolized particles. Filtration of aerosolized particles may be more difficult during open surgery.
  5. There may be enhanced risk of viral exposure to proceduralists/ endoscopists from endoscopy and airway procedures. When these procedures are necessary, strict use of PPE should be considered for the whole team, following Centers for Disease Control (CDC, https://www.cdc.gov) or WHO (https://www.who.int) guidelines for droplet or airborne precautions. This likely includes, at a minimum, N95 masks and face shields. (5, 6).

Practical Measures for Surgery:

  1. Consent discussion with patients must cover the risk of COVID-19 exposure and the potential consequences.
  2. If readily available and practical, surgical patients should be tested pre-operatively for COVID-19.
  3. If needed and possible, intubation and extubation should take place within a negative pressure room. (https://www.asahq.org/in-the-spotlight/coronavirus-covid-19-information, https://icmanaesthesiacovid-19.org) (7, 8)
  4. Operating rooms for presumed, suspected or confirmed COVID-19 positive patients should be appropriately filtered and ventilated and if possible, should be different than rooms used for other emergent surgical patients. Negative pressure rooms should be considered, if available.
  5. Only those considered essential staff should be participating in the surgical case and unless there is an emergency, there should be no exchange of room staff.
  6. All members of the OR staff should use PPE as recommended by national or international organization including the WHO or CDC. Appropriate gowns and face shields should be utilized. These measures should be used in all surgical procedures during the pandemic regardless of known or suspected COVID status. Placement and Removal of PPE in should be done according to CDC guidelines.
  7. Electrosurgery units should be set to the lowest possible settings for the desired effect. Use of monopolar electrosurgery, ultrasonic dissectors, and advanced bipolar devices should be minimized, as these can lead to particle aerosolization. (9-15) If available, monopolar diathermy pencils with attached smoke evacuators should be used.
  8. Surgical equipment used during procedures with COVID-19 positive or Persons Under Investigation (PUI) /suspected COVID patients should be cleaned separately from other surgical equipment.

Practical Measures for Laparoscopy

  1. Incisions for ports should be as small as possible to allow for the passage of ports but not allow for leakage around ports.
  2. CO2 insufflation pressure should be kept to a minimum and an ultra-filtration (smoke evacuation system or filtration) should be used, if available.
  3. All pneumoperitoneum should be safely evacuated via a filtration system before closure, trocar removal, specimen extraction or conversion to open.

Practical Measures for Endoscopy (https://www.asge.org/home/joint-gi-society-message-covid-19, https://www.bsg.org.uk)(16, 17)

  1. The ability to control aerosolized virus during endoscopic procedures is lacking, so all members in the endoscopy suite or operating room should wear appropriate PPE, including gowns and face shields. Placement and Removal of PPE should be done according to CDC guidelines.
  2. Since patients can present with gastrointestinal manifestations of COVID-19, all emergent endoscopic procedures performed in the current environment should be considered as high risk.
  3. Since the virus has been found in multiple cells in the gastrointestinal tract and all fluids including saliva, enteric contents, stool and blood, surgical energy should be minimized. (16, 17)
  4. Endoscopic procedures that require additional insufflation of CO2 or room air by additional sources should be avoided until we have better knowledge about the aerosolization properties of the virus. This would include many of the endoscopic mucosal resection (EMR) and endoluminal procedures.
  5. Removal of caps on endoscopes could release fluid and/or air and should be avoided.
  6. Endoscopic equipment used during procedures with COVID-19 positive or PUI patients should be cleaned separately from other endoscopic equipment.

REFERENCES:

  1. Minimally invasive surgery and the novel coronavirus outbreak: lessons learned from Italy. Zheng MH, Boni L, Fingerhut A. Annals of Surgery. 2020. [Accepted for Publication].
  2. Surgical smoke and infection control. Alp E, Bijl D, Bleichrodt RP, Hansson B, Voss A. J Hosp Infect. 2006 Jan;62(1):1-5. Epub 2005 Jul 5.
  3. Detecting hepatitis B virus in surgical smoke emitted during laparoscopic surgery. Kwak HD, Kim SH, Seo YS, et al. Occup Environ Med. 2016, 73:857––863.
  4. Surgical smoke may be a biohazard to surgeons performing laparoscopic surgery. Choi SH, Kwon TG, Chung SK, Kim TH. Surg Endosc. 2014, 28 (8): 2374-80.
  5. Coronavirus (COVID-19) outbreak: what the department of endoscopy should know. Repici A, Maselli R, Colombo M, Gabbiadini R, Spadaccini M, Anderloni A, Carrara S, Fugazza A, Di Leo M, Galtieri PA, Pellegatta G, Ferrara EC, Azzolini E, Lagioia M. Gastrointest Endosc. 2020 Mar 13. pii: S0016-5107(20)30245-5. doi: 10.1016/j.gie.2020.03.019. [Epub ahead of print]
  6. Perioperative Considerations for the 2019 Novel Coronavirus (COVID-19).
  7. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Wax RS, Christian MD. Can J Anaesth. 2020 Feb 12 [Epub ahead of print].
  8. Liana Zucco, Nadav Levy, Desire Ketchandji, Mike Aziz, Satya Krishna Ramachandran, Anesthesia Patient Safety Foundation, https://www.apsf.org/news-updates/perioperative-considerations-for-the-2019-novel-coronavirus-covid-19/, 2020 Feb 12.
  9. Surgical Smoke and the Orthopedic Implications. The Internet Journal of Orthopedic Surgery. Parsa RS, Dirig NF, Eck IN, Payne III WK. 2015, Volume 24 Number 1.
  10. Risk of acquiring human papilloma-virus from the plume produced by the carbon dioxide laser in the treatment of warts. Gloster HM Jr, Roenigk RK. J Am Acad Dermatol. 1995, 32:436–41.
  11. Papillomavirus in the vapor of carbon dioxide laser-treated verrucae. Garden JM, O‘Banion MK, Shelnitz LS, et al. JAMA. 1988, 259:1199––1202.
  12. Human papillomavirus DNA in CO2 laser-generated plume of smoke and its consequences to the surgeon. Ferenczy A, Bergeron C, Richart RM. Obstet Gynecol. 1990, 75:114-118.
  13. Presence of human immunodeficiency virus DNA in laser smoke. Baggish MS, Poiesz BJ, Joret D, Williamson P, Refai A. Lasers Surg Med. 1991;11:197–203 .
  14. Experimental study of the potential hazards of surgical smoke from powered instruments. In SM, Park DY, Sohn IK, et al. Br J Surg. 2015, 102:1581––1586.
  15. Studies on the transmission of viral disease via the CO2 laser plume and ejecta. Wisniewski PM, Warhol MJ, Rando RF, Sedlacek TV, Kemp JE, Fisher JC. J Reprod Med. 1990, 35:1117–23.
  16. COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission. Gu J, Han B, Wang J. Gastroenterology. March 3 2020 [Epub ahead of print].
  17. ASGE | JOINT GI SOCIETY MESSAGE- COVID-19 Clinical insights for our community of gastroenterologists and gastroenterology care providers. https://www.asge.org/home/joint-gi-society-message-covid-19

Did you find this information helpful?
Please consider joining SAGES or making a donation to the SAGES Education and Research Foundation so we can continue to bring content like this to the surgical community for free.

Filed Under: Blog, COVID-19 Tagged With: coronavirus, covid19, eaes, surgical recommendations

The Coronavirus Global Surgical Collaborative (CVGSC)

March 24, 2020 by Horacio Asbun

An initiative sponsored by SAGES in collaboration with EAES, AEC, KSELS* 

A group of surgical leaders from affected countries have joined to discuss what they are learning during this Covid-19 Global crisis. The following is a brief summary of what they feel may be useful information to disseminate to the surgical community:

Lack of taste and smell:

A minority of patients present with decreased sense of taste and/or smell as their first symptom. This can precede any other symptom. Several ENT physicians have been exposed to Covid-19 because they unsuspectingly examined these patients in their offices

Abdominal Pain:

A minority of patients can present with abdominal pain and possible associated fever. In some instances, even mimicking appendicitis. They usually have accompanying diarrhea, loss of appetite and or vomiting. When the clinical presentation of a suspected acute abdominal diagnosis appears somewhat atypical, including only mildly raised WBC or CRP, a CT of the abdomen including the chest can be paramount to avoid taking the patient to surgery.

Chest Ultrasound:

As the number of patients increases, a useful diagnostic modality could be thoracic ultrasound. Six areas of the thorax are studied at each side. Please follow this link to see a 5 minute video of how to perform a diagnostic ultrasound or watch it below, courtesy of San Matteo Hospital, Pavia, Italy –

Testing:

There is a wide range of sensitivity and wait times for results of the Covid-19 diagnostic test. The provider swabbing the patient should know how to do it correctly and has the experience in doing it. A superficial, incorrect swabbing is discouraged since it may lead to a false negative result.


Participants:

Drs. Horacio Asbun (Lead), Mohammed Abu Hilal, Jaap Bonjer, Nicolas Demartines, Ho-Seong Han, Salvador Morales, Andrea Pietrabissa, Aurora Pryor, Christopher Schlachta, Eduardo Targarona

Other Surgical Societies/leaders are welcome to participate in future discussions. Please contact SAGES Executive Director, Sallie Matthews at [email protected] if interested in being considered for participation.


*GENERAL DISCLAIMER:  

The following is intended to provide our members with information arising from the experience of our colleagues from Europe and Asia who experienced the pandemic first.  While the information provided is from very reliable sources, it is NOT evidence based data, since there was no time to test its validity on scientific grounds. It is merely an attempt to share practical advice based upon prior experience and current knowledge.

Filed Under: Blog, COVID-19, Notes from the Battlefield Tagged With: coronavirus, covid-19, cvgsc, symptoms, ultrasound, video

A Message from the SAGES President

March 23, 2020 by SAGES Webmaster

These are uncertain times for all of us facing the COVID-19 pandemic. As surgeons, we are seeing a halt to our elective practice, a transition to virtual clinic visits, and potential redeployment into areas of the front line in ICUs or medical wards that are outside of our regular practice patterns. Healthcare workers overall are facing potential equipment shortages, including in personal protective equipment. SAGES is working hard to provide resources to help you navigate this unfamiliar landscape. I can’t believe it was only two weeks ago that we postponed our annual meeting until August.

On March 19, we issued a statement recommending considerations for surgical practice during the pandemic, but landscapes are local, and the situation is in rapid evolution. The March 19 statement was written by the Quality, Outcomes and Safety Committee, led by Jonathan Dort, Konstantinos Spaniolas and Deborah Keller with input from a broad group of our other SAGES leaders. Please keep in mind that even though a significant effort is placed in bringing you the best information, our recommendations are not meant to be rigorous scientific guidelines and they may evolve as additional evidence becomes available.

The Acute Care committee led by Rob Lim with co-authors Kim Davis, Andre Campbell and Mike Cripps shared their critical care experience with us in a primer for those of us who will be expanding our scope of practice by necessity. We also have a primer on Telehealth on our site written by Kevin Wasco, Shawn Tsuda, Christopher Schlachta, Caitlin Halbert and Jonathan Dort with input from our SAGES executives. The included codes may help you navigate this useful modality.

Other resources on our webpage come from our global partners. Horacio Asbun, SAGES’ President-elect, has established a coalition called Corona Virus Global Surgical Collaborative of front line COVID-fighters from across the globe. We are meeting virtually weekly to exchange experiences and best practices. We plan to share lessons learned on our website and in publication. The first set of documents from this coalition are from Salvador Morales and the Spanish Association of Surgeons. We are working to translate these into English, but believe many of you will still find them helpful in their current form. They are not formally endorsed. Keep posted as there is more to come!

We have set up a webpage detailing our recommendations and resources with links to other helpful sites for the latest information on COVID-19. Please visit:

https://www.sages.org/category/covid-19/

We are updating it almost daily. To avoid further email saturation, updates and new statements will be posted there instead of emailed.

Thank you for all of the hard work all of you do and your commitment to our SAGES Mission: Innovate, educate and collaborate to improve patient care.

Most sincerely,

Aurora

Filed Under: Blog, COVID-19, President Posts Tagged With: aurora, coronavirus, covid-19, pryor, recommendations, statements

UPDATED – SAGES Telehealth Primer in Response to the COVID-19 Pandemic

March 22, 2020 by Shawn Tsuda

Drafted by the SAGES COVID-19 Rapid Response Team. This was approved by the SAGES Executive Committee.

This document was updated on March 23, 2020

Introduction:

The use of telemedicine is essential to ensure uninterrupted medical and surgical care to our patients during the COVID-19 pandemic. In response to the COVID-19 pandemic, SAGES has prepared this special primer on telehealth. Telehealth is the use of telecommunications technology to deliver a wide breadth of health services including diagnosis, consultation, treatment, education, monitoring, and healthcare administration. Prudent use of technology may facilitate ongoing interaction with patients, other physicians, students, residents, administrators, and caregivers.

There are a number of platforms that allow for both synchronous interactions using real-time audio, video, or messaging, and asynchronous “store and forward” transfers of medical records or images. As national and state policy is adjusting in response to the pandemic, it is important to closely follow updates to policy regarding privacy, coding, and reimbursement to provide optimal care to your patients via telehealth, while being aware that certain policy adjustments may be temporary. When uncertain, we recommend consulting with your institution’s compliance officer, healthcare compliance attorney, the Centers for Medicare and Medicaid Services (cms.gov), and the U.S. Department of Health and Human Services (hhs.gov).

Clinical Triage:

As outlined in the recently published SAGES COVID-19 guidelines, all elective non-urgent procedures should be postponed until after the pandemic shows adequate evidence of a decline of new cases. All office visits that cannot be delayed and that do not require a physical exam should be eligible for a telehealth encounter. The use of relaying images for evaluation of pathology or wound progress should be done within the guidelines covered in the visit guidelines section below.

Telehealth Privacy, Licensure, Coding, and Reimbursement during the COVID-19 Pandemic

UNITED STATES

  1. When possible, technology compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) should be used for telehealth involving Protected Health Information (PHI) (www.hhs.gov/answers/hipaa).
    1. HIPAA Compliant Technology: Common telecommunications platforms such as GoToMeeting, Skype for Business, or Microsoft Teams can be used safely when discussing PHI by entering into a business associate agreement (BAA) with the entity. There are also a number of health technology companies dedicated to facilitating HIPAA-compliant communication – e.g., InTouch Health, Doximity Dialer, Starleaf, Amwell, and Teladoc.
    2. Non-HIPAA Compliant Technology: Social communication technologies such as Facetime, Zoom, WhatsApp, text messaging, and email may be appropriate for use during the pandemic when there are no other alternatives. Effective March 17, 2020, the Centers of Medicare and Medicaid Services (CMS) and the U.S. Department of Health and Human Services announced they will waive potential HIPAA penalties and will not perform audits during the COVID-19 nationwide public health emergency for telehealth services that are used in good faith.

Licensure

Prior to the current COVID-9 pandemic physicians had to have a license for each state they practice medicine including telemedicine.   As telemedicine has become more utilized in the past several years, legislature to support its use across state lines has produced the Interstate Medical Licensure Compact (or IMLC).  Physicians are able to qualify for licensing outside of their state of principle license through the IMLC. There are currently 29 states, in addition to the District of Columbia and Territory of Guam, participating in the agreement.  During the pandemic, CMS has waived the interstate licensing possibly allowing physicians to practice across state lines.   Final approval for CMS and Medicaid is determined by the individual states.  Several states have already followed CMS and eased the restrictions with regards to practicing across state lines. Private payers are starting to expand  their policies to match the CMS and individual state changes. This licensure issue is changing rapidly.   For more information, follow the Federation of State Medical Boards COVID-19 updates and the latest on State Emergency declarations and licensing waivers

Providers

Services must be provided by a physician or authorized practitioner. Hospitals, physicians, physicians assistants, nurse practitioners, psychologists, dietitians, and social workers may provide telehealth.

Coverage

As of March 6, 2020, CMS will temporarily provide coverage for telehealth services throughout the country for the duration of the COVID-19 pandemic. The expanded benefits will allow greater flexibility for providers and patients utilizing this critical tool to care for patients remotely. Prior to this expansion, telehealth services were only covered for patients receiving services in rural or remote locations and they were not allowed to receive the telehealth service from their home. Patients are now able to receive telehealth services in any healthcare facility, including a physician office, skilled nursing facilities, and in the home. For more information, visit the Medicare Telemedicine Health Care Provider Fact Sheet.

Medicaid is state-dependent but already provides a varying degree of flexibility to states regarding telehealth. The Center for Connected Health Policy, a non-profit organization focused on national telehealth policy, has created an up-to-date resource for State Telehealth Laws. At the current time, California is the only state to enact a law to remove barriers to telehealth during the current pandemic.

Private payers are starting to follow suit with CMS. Large commercial insurers, such as Aetna, BlueCross Blue Shield, Cigna, Humana, UnitedHealthcare and more are moving to expand telehealth policy. For some, it is expressed that these policy changes may become permanent, even after the current public health crisis has resolved.

Regardless of coverage, receiving and providing telehealth medicine is not prohibited. Rather, the controversy lies in its reimbursement and coverage.

Documentation

Despite relaxed policy on the use of telemedicine, proper documentation is still imperative. Many of the technologies utilized for telemedicine can be linked or embedded in the electronic medical record (EMR) for easier documentation.

Written informed consent for the use of telehealth should be obtained whenever possible. Verbal consent is allowed during this pandemic. It is considered best practice by SAGES to discuss both the use of telehealth and the technology being utilized.

Complete documentation should include:

  1. The informed consent discussion.
  2. Statement that service was provided via telehealth, including the type of telehealth being utilized. The potential use of a non-HIPPA compliant technology should be mentioned, as well.
  3. The location of the patient and provider.
  4. The roles of people participating if not otherwise clearly stated.
  5. Documentation to support appropriate coding.

For telehealth visits occurring in place of office visit during the pandemic, proper documentation is still vital. An example of this documentation is as follows:

“This visit has been changed from an in-person office visit to a phone visit to lower the risk of exposure and/or spread of the current pandemic with the COVID-19 virus. This is based on guidelines from the CDC and other health agencies.”

Coding and Billing

Telehealth Outpatient Visits

Telehealth is defined as synchronous audio and visual visits between patient and clinician. There must be capability to have real time two-way audio-visual interaction.

New Patients

CPT Codes 99201-99205 for new patients, POS 02 for Telehealth Medicare and modifier 95 for Commercial Payers

CPT Code RVU Minutes
99201 0.48 10
99202 0.93 20
99203 1.42 30
99204 2.43 45
99205 3.17 60

Established Patients

CPT Codes 99210-99215 for established patients, POS 02 for Telehealth Medicare and modifier 95 for Commercial Payers.

CPT Code RVU Minutes
99211 0.18 5
99212 0.48 10
99213 0.97 15
99214 1.50 25
99215 2.11 40

Modifiers

POS Code 02 Services rendered via synchronous interactive audio and video telecommunication. Use after E/M code to bill for telehealth.
GT Services rendered via synchronous interactive audio and video telecommunication. No longer required after 2018. Replaced by POS code 02
GQ Telehealth via asynchronous telecommunications. Required if part of federal demonstration program for Alaska and Hawaii
95 Synchronous telecommunications service, typically overlaps with GT and now POS code 02.

Q3014 Telehealth Originating Site Facility Fee

This is the facility fee for the originating site (physician’s office, hospital, etc) for telehealth visit. Not applicable in the current pandemic environment.

Additional HCPCS category/class 2 codes for interest can be found here: Coding and Documentation Guidelines for APPs and Teaching Services_03-18

Inpatient/Emergency Room Telehealth Consultations

Video interaction is required per CMS.

Consultations ordered for Patients Under Investigation (PUI) and COVID-19 Positive Patients in the Emergency Room and/or Inpatient status require a request for an inpatient or emergency department telehealth consultation from an appropriate source and a report of the consulting provider’s findings and recommendations.

Initial Visit Subsequent Visit
G0425 30 minutes G0406 15 minutes
G0426 50 minutes G0407 25 minutes
G0427 70 minutes G0408 35 minutes

Telephone Evaluation and Management

Telephone evaluation and management services provided by a physician or healthcare professional to established patient, parent or guardian. No E/M billing can be used within the previous 7 days or in the following 24 hours.

The following codes are currently not covered by CMS but may be covered by commercial payers.

Physician billing CPT Code QNP* code RVU Minutes
99441 98966 0.25 5-10
99442 98967 0.50 11-20
99443 98968 0.75 21-30

*Qualified NonPhysician (QNP): dietician, speech pathologist, physical/occupational therapist, social worker.

Digital Visits

Digital Visits using technology for evaluating the possible need for an office visit. Communication must be patient driven. This does not lead to E/M service. This is for established patients only for a time limited to 7 days.

For CMS use HCPCS codes G2010-G2012. For more details, visit CMS.gov. For commercial payers, use codes 99421-99423. Additional information, including information regarding remote patient monitoring, can be found through the AMA Quick Guide to Telemedicine.

E-Consultations

Interprofessional consultations are provider to provider consultations via telephone, internet or EHR. Must include a verbal and written consultative report to the patient’s treating physician. Codes 99446-99449 are typically used. Where appropriate, 99451-99452 codes may be alternatively used.

COVID-19 ICD-10 Coding Guidelines

Effective February 20, 2020, new diagnosis coding guidelines were released for encounters related to the COVID-19 Coronavirus Outbreak. These guidelines can be found here: https://www.cdc.gov/nchs/data/icd/ICD-10-CM-Official-Coding-Gudance-Interim-Advice-coronavirus-feb-20-2020.pdf

CANADA:

For surgeons practicing in Canada, several resources are available for conducting a practice by telehealth and for circumstances specific to the SARS-nCoV-2 pandemic.

  1. The Canadian Medical Protective Association (CMPA) offers advice on liability for duty of care and for treating patients with COVID-19 via telehealth. These can be found at: https://www.cmpa-acpm.ca/en/covid19.
    1. With respect to duty of care, the professional obligations and legal principles that usually apply to all surgeons continue in the context of COVID-19. Where in-person consultation is not required, consultation by telephone or other means of telehealth (virtual care) may be expected.
    2. The CMPA resource for practising telehealth can be found here: https://www.cmpa-acpm.ca/en/membership/protection-for-members/principles-of-assistance/practising-telehealth.
    3. While surgeons are reminded to follow their Colleges’ guidelines for delivery of telehealth, two important considerations should be addressed:
      1. The technology used for telehealth should be specified, in the medical record, for each encounter.
      2. Informed consent for the use of virtual care should be obtained. A template is available at: https://www.cmpa-acpm.ca/static-assets/pdf/advice-and-publications/risk-management-toolbox/com_16_consent_to_use_electronic_communication_form-e.pdf
  2. In Ontario, since 2006, telemedicine has been offered securely through the Ontario Telemedicine Network (OTN). Until recently, these services have required patients to go to a healthcare facility host site. Since 2014, the OTN has piloted direct-to-patient video visits using OTNinvite, a secure videoconferencing service that allows physicians and patients to connect from any location in Ontario using their own electronic device. This service is only available to family doctors. In accordance with the Ontario Medical Association (OMA), surgeons wishing to provide virtual care to patients are able to do so using non-OTN technology with the following conditions:
    1. A temporary fee code for non-OTN, specialist, virtual care (K083) has been developed.
    2. Informed consent is obtained, as above
    3. Documentation of technology employed is recorded, as above.
    4. An OMA recommended patient information text, for surgeon websites or office posting, explaining the limitations of virtual care technology and potential privacy concerns is available here: https://www.oma.org/member/section/practice-&-professional-support/virtual-care?type=topics, as is a recommended virtual care disclosure text for inclusion in eth electronic medical record.
    5. OMA Recommended virtual care platforms are available here: https://content.oma.org/wp-content/uploads/private/VC-Covid19-visual-V4.pdf

Did you find this information helpful?
Please consider joining SAGES or making a donation to the SAGES Education and Research Foundation so we can continue to bring content like this to the surgical community for free.

Filed Under: Blog, COVID-19 Tagged With: coronavirus, covid-19, HIPAA, licensure, privacy, TAVAC, technology, teleconsult, telehealth, telemedicine

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Go to Next Page »

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064
1-310-437-0544
[email protected]
Monday - Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons